CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...